Co-Authors
This is a "connection" page, showing publications co-authored by Peter Galle and Markus Neurath.
Connection Strength
0.421
-
IRF4 regulates IL-17A promoter activity and controls ROR?t-dependent Th17 colitis in vivo. Inflamm Bowel Dis. 2011 Jun; 17(6):1343-58.
Score: 0.116
-
Treatment of Crohn's disease with leflunomide as second-line immunosuppression : a phase 1 open-label trial on efficacy, tolerability and safety. Dig Dis Sci. 2008 Apr; 53(4):1025-32.
Score: 0.092
-
Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol. 2004 May 01; 172(9):5149-53.
Score: 0.073
-
Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis. Gastroenterology. 2019 02; 156(3):692-707.e7.
Score: 0.049
-
Prediction of clinical outcomes in Crohn's disease by using confocal laser endomicroscopy: results from a prospective multicenter study. Gastrointest Endosc. 2018 Jun; 87(6):1505-1514.e3.
Score: 0.046
-
Elevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitis. Nat Commun. 2017 04 28; 8:15069.
Score: 0.045